PharmiWeb.com - Global Pharma News & Resources
04-Feb-2021

Pneumonia Testing Market Analysis Revealing Key Drivers, Growth Trends through 2026 | Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd. etc.

Pneumonia is a respiratory disease caused by bacteria, viruses or fungi. It primarily affects the small air sacs known as alveoli and the most common type of bacteria that causes pneumonia is Streptococcus pneumonia.  Fever, chills, cough, shortness of breath and fatigue are some of the major symptoms of pneumonia. Blood tests, chest X-rays, pulse oximetry, and Sputum test are the test used to detect pneumonia.  For instance, CT scan, Pleural fluid culture are some of the other tests that are used among older patients age 65.

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/1742

The blood tests are used to confirm an infection and chest X-ray also helps the doctor to diagnose pneumonia and determine the extent and location of the infection. The pulse oximetry test is performed to measure the oxygen level in the blood, as Pneumonia can impact the transportation of oxygen to the bloodstream. Apart from all this test the sputum test is used to analyses or pinpoints the cause of the infection, the sample of fluid taken out from the lungs, which is taken after deep cough.

CT scan test is performed to obtain the affected condition of lungs and if patients show some serious symptoms of health conditions pleural fluid culture test is carried out which is done by putting a needle between the ribs from the pleural area to analyze the type of infection.

Pneumonia Testing Market Dynamics

The recent advancements in pneumonia testing systems, such as the development of enhanced nucleic acid detection tests and advancement in POC tests is the major factor fueling market growth. POC tests offer multiple benefits such as ease of use and rapid results. For instance, the urinary antigen is an extremely-effective rapid test that allows targeted therapy for legionnaire at the point-of-care itself.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1742

Moreover, the rising adoption of molecular diagnostic tests in the developing economy is projected to offer lucrative opportunities to the pneumonia testing market. This can be attributed to the increased application of biomarkers in molecular diagnostics, owing to the advantages of biomarkers such as aiding in early detection of specific diseases, supports the molecular diagnostics test for the pneumonia testing market.

Traditionally, cultures are were used to detect pneumonia causative organisms, this was a time-consuming process with a higher chance of error and in some cases, culture identification is not readily available and this increases the mortality rate of pneumonia cases caused by it.

Pneumonia Testing Market – Regional Insights

North America accounted for the largest share in the pneumonia testing market, followed by the Europe market in 2016. This is attributed to rising popularity for POC tests within the healthcare sector. Further, the rising research and development activities for the development of more advanced PCR-based technologies, which could be used for faster results is also presumed to fuel market growth.

Further, Europe accounts for the second-largest share in the pneumonia testing market, and this can be attributed to their well-developed healthcare infrastructure and a higher awareness regarding the Pneumonia testing.

Furthermore, various pharmaceutical and biotechnological companies are focusing on expanding in the Asia Pacific region, to maximize their R&D efforts as the Asia Pacific region provides better access to patients for clinical trials, with lower operational costs. Moreover, rising government investment in research and development is also projected to foster the growth of Pneumonia Testing in the Asia Pacific region.

Pneumonia Testing Market – Competitive Analysis

Major players are focused on collaborations and mergers, to enter the pneumonia testing market in order to increase their share. For instance, in April 2017, Abbott acquired Alere, which dominated POC testing for pneumonia testing market with its BinaxNOW Streptococcus pneumoniae antigen card for bacterial pneumonia and BinaxNOW RSV Card for viral pneumonia.

Key players operating in the market are Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/pneumonia-testing-market-1742

Pneumonia Testing Market – Taxonomy:

By Product Type:

  • Analyzers
  • Point-Of-Care (POC)
  • Non-POC
  • Consumables

By Technology:

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunofluorescence
  • Western Blot
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • Molecular Diagnostics
  • Others

By End-User

  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 04-Feb-2021